Skip to main content
Clinical Trials/ACTRN12620001081909
ACTRN12620001081909
Not yet recruiting
未知

Exercise medicine as chemotherapy adjunct: the feasibility and efficacy of a multi-component program in pancreatic cancer patients receiving neoadjuvant therapy (The EXPAN Project)

Edith Cowan University0 sites40 target enrollmentOctober 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
pancreatic cancer
Sponsor
Edith Cowan University
Enrollment
40
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 20, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with borderline resectable or locally advanced pancreatic adenocarcinoma as per the definition proposed by the Australasian Gastro\-Intestinal Trials Group and waiting to commence or within four weeks after starting their prescribed chemotherapy

Exclusion Criteria

  • \- Treatment for another primary cancer within the last 12 months, or another ongoing active primary malignancy;
  • \- Recurrent pancreatic cancer with or without exposure to previous chemotherapy
  • \- Anticipating to undergo major surgery for non\-cancer diseases within six months
  • \- Participating in structured exercise training greater than or equal to 2 days/week in the previous month
  • \- ECOG (Eastern Cooperative Oncology Group) performance score greater than 1
  • \- Contraindications to exercise training at moderate intensity

Outcomes

Primary Outcomes

Not specified

Similar Trials